Ligand Pharmaceuticals Incorporated Stock Pattern Recognition Identical Three Crows

LGND Stock  USD 116.55  2.09  1.76%   
Ligand Pharmaceuticals pattern recognition tool provides the execution environment for running the Identical Three Crows recognition and other technical functions against Ligand Pharmaceuticals. Ligand Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Identical Three Crows recognition function is designed to identify and follow existing trends. Ligand Pharmaceuticals momentum indicators are usually used to generate trading rules based on assumptions that Ligand Pharmaceuticals trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Identical Three Crows pattern describes Ligand Pharmaceuticals trend with bearish reversal signal.

Ligand Pharmaceuticals Technical Analysis Modules

Most technical analysis of Ligand Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ligand from various momentum indicators to cycle indicators. When you analyze Ligand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ligand Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ligand Pharmaceuticals Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ligand Pharmaceuticals Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing Ligand Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ligand Pharmaceuticals's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ligand Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Ligand Pharmaceuticals, we also check how macroeconomic factors affect Ligand Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2024 2025 (projected)
Dividend Yield0.480.42
Price To Sales Ratio8.479.2
Hype
Prediction
LowEstimatedHigh
113.82116.86119.90
Details
Intrinsic
Valuation
LowRealHigh
104.90121.25124.29
Details
Naive
Forecast
LowNextHigh
116.68119.72122.77
Details
7 Analysts
Consensus
LowTargetHigh
131.04144.00159.84
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ligand Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ligand Pharmaceuticals' short interest history, or implied volatility extrapolated from Ligand Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
Apparel Idea
Apparel
Invested over 90 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 30 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
Chemicals Idea
Chemicals
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
Business Services Idea
Business Services
Invested few shares
Insurance Idea
Insurance
Invested over 200 shares
When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Ligand Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.032
Earnings Share
2.49
Revenue Per Share
8.509
Quarterly Revenue Growth
0.576
Return On Assets
0.013
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.